|
|
 Previous Article | Table of Contents | Next Article 
Blood, Vol. 92 No. 4 (August 15), 1998:
pp. 1308-1316
Transcription Factor B-Cell-Specific Activator Protein
(BSAP) Is Differentially Expressed in B Cells and in Subsets of B-Cell
Lymphomas
Laszlo Krenacs,
Andreas W. Himmelmann,
Leticia Quintanilla-Martinez,
Thierry Fest,
Agostino Riva,
Axel Wellmann,
Eniko Bagdi,
John H. Kehrl,
Elaine S. Jaffe, and
Mark Raffeld
From the Hematopathology Section, Laboratory of Pathology, National
Cancer Institute and the B cell Molecular Immunology Section,
Laboratory of Immunoregulation, National Institute of Allergy and
Infectious Diseases, National Institutes of Health, Bethesda, MD; and
the Department of Pathology, Albert Szent-Gyorgyi Medical University,
Szeged, Hungary.
The paired box containing gene PAX-5 encodes the
transcription factor BSAP (B-cell-specific activator protein), which
plays a key role in B-lymphocyte development. Despite its known
involvement in a rare subtype of non-Hodgkin's lymphoma (NHL), a
detailed examination of BSAP expression in NHL has not been previously reported. In this study, we analyzed normal and malignant lymphoid tissues and cell lines, including 102 cases of B-cell NHL, 23 cases of
T- and null-cell NHL, and 18 cases of Hodgkin's disease. Normal
lymphoid tissues showed strong nuclear BSAP expression in mantle zone B
cells, less intense reactivity in follicular center B cells, and no
expression in cells of the T-cell-rich zones. Monocytoid B cells
showed weak expression, whereas plasma cells and extrafollicular large
transformed B cells were negative. Of the 102 B-cell NHLs, 83 (81%)
demonstrated BSAP expression. All of the 13 (100%) B-cell chronic
lymphocytic leukemias (B-CLLs), 21 of (100%) mantle cells (MCLs), and
20 of 21 (95%) follicular lymphomas (FLs) were positive. Moderate
staining intensities were found in most B-CLL and FL cases, whereas
most MCLs showed strong reactions, paralleling the strong reactivity of
nonmalignant mantle cells. Eight of 12 (67%) marginal zone lymphoma
cases showed negative or low BSAP levels, and 17 of 24 (71%) large
B-cell lymphomas displayed moderate to strong expression. None of the
23 T- and null-cell lymphomas reacted with the BSAP antisera, whereas
in Hodgkin's disease, 2 of 4 (50%) nodular lymphocytic predominance and 5 of 14 (36%) classical cases showed weak nuclear or nucleolar BSAP reactions in a fraction of the tumor cells. Western blot analysis
showed a 52-kD BSAP band in B-cell lines, but not in non-B-cell or
plasma cell lines. We conclude that BSAP expression is largely
restricted to lymphomas of B-cell lineage and that BSAP expression
varies in B-cell subsets and subtypes of B-cell NHL. The high levels of
BSAP, especially those found in large-cell lymphomas and in some
follicular lymphomas, may be a consequence of deregulated gene
expression and suggest a possible involvement of PAX-5 in
certain B-cell malignancies.
This is a US government work. There are no restrictions on its use.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
F. Mora-Lopez, E. Reales, J. A. Brieva, and A. Campos-Caro
Human BSAP and BLIMP1 conform an autoregulatory feedback loop
Blood,
November 1, 2007;
110(9):
3150 - 3157.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Nagel, C. Burek, L. Venturini, M. Scherr, H. Quentmeier, C. Meyer, A. Rosenwald, H. G. Drexler, and R. A. F. MacLeod
Comprehensive analysis of homeobox genes in Hodgkin lymphoma cell lines identifies dysregulated expression of HOXB9 mediated via ERK5 signaling and BMI1
Blood,
April 1, 2007;
109(7):
3015 - 3023.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Kaderali, T. Zander, U. Faigle, J. Wolf, J. L. Schultze, and R. Schrader
CASPAR: a hierarchical bayesian approach to predict survival times in cancer from gene expression data
Bioinformatics,
June 15, 2006;
22(12):
1495 - 1502.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Gulmann, V. Espina, E. Petricoin III, D. L. Longo, M. Santi, T. Knutsen, M. Raffeld, E. S. Jaffe, L. A. Liotta, and A. L. Feldman
Proteomic Analysis of Apoptotic Pathways Reveals Prognostic Factors in Follicular Lymphoma
Clin. Cancer Res.,
August 15, 2005;
11(16):
5847 - 5855.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Atayar, S. Poppema, T. Blokzijl, G. Harms, M. Boot, and A. van den Berg
Expression of the T-Cell Transcription Factors, GATA-3 and T-bet, in the Neoplastic Cells of Hodgkin Lymphomas
Am. J. Pathol.,
January 1, 2005;
166(1):
127 - 134.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Tiacci, S. Pileri, A. Orleth, R. Pacini, A. Tabarrini, F. Frenguelli, A. Liso, D. Diverio, F. Lo-Coco, and B. Falini
PAX5 Expression in Acute Leukemias: Higher B-Lineage Specificity Than CD79a and Selective Association with t(8;21)-Acute Myelogenous Leukemia
Cancer Res.,
October 15, 2004;
64(20):
7399 - 7404.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. B. Baumann Kubetzko, C. di Paolo, C. Maag, R. Meier, B. W. Schafer, D. R. Betts, R. A. Stahel, and A. Himmelmann
The PAX5 oncogene is expressed in N-type neuroblastoma cells and increases tumorigenicity of a S-type cell line
Carcinogenesis,
October 1, 2004;
25(10):
1839 - 1846.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
I. S. Lossos, D. K. Czerwinski, A. A. Alizadeh, M. A. Wechser, R. Tibshirani, D. Botstein, and R. Levy
Prediction of Survival in Diffuse Large-B-Cell Lymphoma Based on the Expression of Six Genes
N. Engl. J. Med.,
April 29, 2004;
350(18):
1828 - 1837.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Marafioti, M. Pozzobon, M.-L. Hansmann, G. Delsol, S. A. Pileri, and D. Y. Mason
Expression of intracellular signaling molecules in classical and lymphocyte predominance Hodgkin disease
Blood,
January 1, 2004;
103(1):
188 - 193.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Marafioti, M. Jones, F. Facchetti, T. C. Diss, M.-Q. Du, P. G. Isaacson, M. Pozzobon, S. A. Pileri, A. J. Strickson, S.-Y. Tan, et al.
Phenotype and genotype of interfollicular large B cells, a subpopulation of lymphocytes often with dendritic morphology
Blood,
October 15, 2003;
102(8):
2868 - 2876.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. F. J. Schop, W. M. Kuehl, S. A. Van Wier, G. J. Ahmann, T. Price-Troska, R. J. Bailey, S. M. Jalal, Y. Qi, R. A. Kyle, P. R. Greipp, et al.
Waldenstrom macroglobulinemia neoplastic cells lack immunoglobulin heavy chain locus translocations but have frequent 6q deletions
Blood,
September 26, 2002;
100(8):
2996 - 3001.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Tarte, J. De Vos, T. Thykjaer, F. Zhan, G. Fiol, V. Costes, T. Reme, E. Legouffe, J.-F. Rossi, J. Shaughnessy Jr, et al.
Generation of polyclonal plasmablasts from peripheral blood B cells: a normal counterpart of malignant plasmablasts
Blood,
July 30, 2002;
100(4):
1113 - 1122.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Z. Rassidakis, L. J. Medeiros, S. Viviani, V. Bonfante, G.-P. Nadali, T. P. Vassilakopoulos, O. Mesina, M. Herling, M. K. Angelopoulou, R. Giardini, et al.
CD20 Expression in Hodgkin and Reed-Sternberg Cells of Classical Hodgkin's Disease: Associations With Presenting Features and Clinical Outcome
J. Clin. Oncol.,
March 1, 2002;
20(5):
1278 - 1287.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. Falini and D. Y. Mason
Proteins encoded by genes involved in chromosomal alterations in lymphoma and leukemia: clinical value of their detection by immunocytochemistry
Blood,
January 15, 2002;
99(2):
409 - 426.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Husson, E. G. Carideo, D. Neuberg, J. Schultze, O. Munoz, P. W. Marks, J. W. Donovan, A. C. Chillemi, P. O'Connell, and A. S. Freedman
Gene expression profiling of follicular lymphoma and normal germinal center B cells using cDNA arrays
Blood,
January 1, 2002;
99(1):
282 - 289.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Torlakovic, A. Tierens, H. D. Dang, and J. Delabie
The Transcription Factor PU.1, Necessary for B-Cell Development Is Expressed in Lymphocyte Predominance, But Not Classical Hodgkin's Disease
Am. J. Pathol.,
November 1, 2001;
159(5):
1807 - 1814.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Tunyaplin, M. A. Shapiro, and K. L. Calame
Characterization of the B lymphocyte-induced maturation protein-1 (Blimp-1) gene, mRNA isoforms and basal promoter
Nucleic Acids Res.,
December 15, 2000;
28(24):
4846 - 4855.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Stein, H.-D. Foss, H. Durkop, T. Marafioti, G. Delsol, K. Pulford, S. Pileri, and B. Falini
CD30+ anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features
Blood,
December 1, 2000;
96(12):
3681 - 3695.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. Falini, M. Fizzotti, A. Pucciarini, B. Bigerna, T. Marafioti, M. Gambacorta, R. Pacini, C. Alunni, L. Natali-Tanci, B. Ugolini, et al.
A monoclonal antibody (MUM1p) detects expression of the MUM1/IRF4 protein in a subset of germinal center B cells, plasma cells, and activated T cells
Blood,
March 15, 2000;
95(6):
2084 - 2092.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H.-D. Foss, R. Reusch, G. Demel, G. Lenz, I. Anagnostopoulos, M. Hummel, and H. Stein
Frequent Expression of the B-Cell-Specific Activator Protein in Reed-Sternberg Cells of Classical Hodgkin's Disease Provides Further Evidence for Its B-Cell Origin
Blood,
November 1, 1999;
94(9):
3108 - 3113.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
